Industry Events Dual-carbon Innovations & Startups Competition Find Investors About Us

Sectors

All investors

114 institutional investors

Stage preference

Types of funds

Raked by

GL Ventures

Investments: 425

Funds: 38

Hillhouse Investment is a venture capital brand under the Hillhouse Group that focuses on investing in early-stage innovative enterprises. Since our establishment, Hillhouse Group has always focused on early-stage technological innovation investment in projects including Horizon Robotics, BeiGene, ZOOM, Blue Moon, and Ijovo.

Zhuhai, Guangdong Province
Gaorong Capital

Investments: 465

Funds: 12

Founded in 2014, Gaorong Capital is one of the most active venture capital institutions in China. Gaorong Capital profoundly cultivates innovative and entrepreneurial fields such as new consumption, new technology, medical care and health, and invests in innovative and growing enterprises. Up to now, Gaorong has invested in more than 200 enterprises. In the fields of new consumption, we continue to look for opportunities in the domains of "new e-commerce", "new retail", "new brand", "new entertainment" and "new infrastructure"; in the field of new technologies, Gaorong is deeply involved in new technology fields such as artificial intelligence, intelligent hardware, robots, chips, corporate services and industrial upgrading; in the field of medical and health care, we invest in outstanding enterprises in digital health, medical services, new drug research and development, medical devices and testing.

Beijing
GGV Capital

Investments: 763

Funds: 15

GGV Capital is a venture capital company focusing on global early and mid-stage enterprises. We manage a total of 17 funds with assets of US$9.2 billion, with offices in Silicon Valley, San Francisco, Shanghai, Beijing, and Singapore. GGV Capital focuses on startups in the fields of consumption and new retailing, Internet services, cutting-edge technology, enterprise services, and cloud. We have invested in more than 400 companies, including Alibaba, Didi, Qunar, Airbnb, Full Truck Alliance, and Toutiao. By the end of 2020, GGV had 281 companies under management. We pay long-term attention to the global market and dive into localization and integration. We have accumulated unique resources and will fully support entrepreneurs to continue exploring and innovating.

Shanghai
Warburg Princus

Investments: 247

Funds: 1

Warburg Pincus is a world's leading private equity investment institution, focusing on growth investment. Warburg Pincus is committed to cooperating with entrepreneurs to build enterprises with long-term sustainable value. At present, Warburg Pincus manages more than 85 billion US dollars of assets worldwide and invests in more than 250 enterprises in different industries and different stages of development. Since its establishment in 1966, Warburg Pincus has raised 21 private equity funds and 2 real estate funds, and has invested more than 106 billion US dollars in 1,000+ enterprises in over 40 countries around the world. Since entering the Chinese market in 1994, Warburg Pincus has invested a total of 15.6 billion US dollars in more than 150 domestic enterprises in various industries, making it one of the largest and most active international private equity investment institutions in China. At present, its investment focuses on six major areas, namely medical and health care, industrial technology, greater consumption, science and technology, financial services and real estate.

Beijing
Oceanpine Capital

Investments: 83

Funds: 17

Oceanpine Capital is an institutional growth equity investment company that invests in innovative and disruptive growth companies in TMT and health care, which are the driving forces of the newly regulated future economy. Oceanpine Capital believes in long-term value investment and provides strategic financing resources and operational support for invested enterprises. The trading types of Oceanpine Capital are oriented to early growth and growth capital. Since its inception, Oceanpine Capital has invested in more than 70 companies in China and the U.S., mostly in the TMT and healthcare sectors, with more than a dozen of them making successful initial public offerings. The total investment amount has exceeded US $3 billion. Invested enterprises include Hina Battery, Svolt, BEST Semiconductor, Shansong, Mingmed, Giant Biogene, etc.

Hong Kong